CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Vnitřní lékařství, 50, 2004, č. 7, s. 544 - 549
 
Overweight and Obesity - risk Factors of the Development and Progression of Renal Disease 
Šebeková K.1, Klassen A.2, Bahner U.2, Heidland A.2 

1Vedecko-výskumná základňa Slovenskej zdravotníckej univerzity, Ústav preventívnej a klinickej medicíny, Bratislava, Slovenská republika, vedúci doc. MUDr. Martin Gajdoš, CSc. 2Kuratórium pre dialýzu a transplantáciu obličiek, Würzburg, SRN, vedúci doc. Dr. Udo Bahner, Ph.D.
 


Summary:

       Overweight/obesity represent an underestimated risk factor of renal disease. The incidence of obesity-related glomerulopathy (ORG) tremendously increased within the last decade. The first sign of renal damage in overweight conditions is microalbuminuria or proteinúria, indicating the potential risk of its progression to renal insufficiency and the development of premature cardio-vascular events. In the early stage of obesity renal hemodynamics are characterized by a renal hypercirculation and glomerular hyperfiltration, particularly in the presence of hypertension. The hyperfiltration is especially harmful in patients with pre-existing inflammatory and metabo-lic renal disease, or under the conditions of reduced renal mass. Histopathologically, ORG is characterized by glomerulomegaly with/without signs of focal segmental glomerulosclerosis. Pathogenetically, numerous factors are involved, e.g. enhanced glomerular capillary pressure, ad-renergic nerve overactivity, inappropriate activation of the renin-angiotensin-aldosterone systém, insulin resistance, hyperinsulinemia and hyperleptinémia, dyslipidémia, enhanced clotting tendency and sodium retention. Diabetic nephropathy is one of the most serious complications of obesity-induced diabetes. In the industrial nations type 2 diabetes is the single most frequent cause of end-stage renal disease. After kidney transplantation, overweight/obesity is associated with a less favourable prognosis for the survival of the graft and the patient. Incidence of renal cell carcinomas is enhanced in overweight/obesity. Obesity-related renal disease may be preven-ted/postponed by an early weight reduction, by dietary intervention combined with physical exer-cise. In the advanced stages of renal disease benefits of weight reduction are minimal. Concomitant administration of angiotensin-converting-enzyme inhibitors or angiotensin II recep-tor 1 blockers exerts antiproteinuric effects and thereby aid in retarding the disease progression. Aimed prevention and treatment of obesity represent a challenge for the healthcare systém. The concerted action of physicians, patients and the public health authorities is needed.

        Key words: Obesity - Hypertension - Metabolic syndrome - Diabetic nephropathy - Glomerulosclerosis - Weight reduction
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER